Chief Investigators and Program Leads

Professor Seth Masters, CRE director
Centre Head, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research; Research Group Head, Innate Immune and Autoinflammatory Disease

Professor Kate Schroder, Joint Program Lead, Inflammasomopathies
Inflammasome Lab, The University of Queensland

Professor Michael Rogers, Joint Program Lead, Inflammasomopathies
Laboratory Head, Rogers Lab, The Garvan Institute of Medical Research

Professor Carl Walkley, Joint Program Lead, Interferonopathies
Research Group Head, RNA Biology and Innate Immune Sensing, Hudson Institute of Medical Research and Monash University

Dr Sophia Davidson, Joint Program Lead, Interferonopathies
Research Group Head, Neuroinflammation and Neurodegeneration, Hudson Institute of Medical Research

Dr Najoua Lalaoui, Joint Program Lead, Relopathies
Group Leader, Peter MacCallum Cancer Centre

Professor Shane Grey, Joint Program Lead, Relopathies
Head of School, The University of New South Wales

Associate Professor Paul Gray, Clinical Co-ordination
Joint Head of Immunology and Infectious Diseases, Sydney Children’s Hospital, Randwick

Dr Samar Ojaimi, Clinical Co-ordination
Head, diagnostic immunology laboratory at Monash Health, Monash Health

Ms Karen Raymond, Patient Advocate

Associate Investigators

Ms Sharon Kensell, FMFandAID Australia

Professor Matt Trau, The University of Queensland

Dr Marcia Munoz, The Garvan Institute of Medical Research

Associate Professor Ashley Mansell, Latrobe

Professor Natalie Trevaskis, Monash University

Dr Maria Tanzer, Walter and Eliza Hall Institute of Medical Research

Dr Alberto Pinzon-Charry, Queensland Children’s Hospital

Dr Georgina Tiller, The Royal Children’s Hospital Melbourne

Dr Michael O’Sullivan, Perth Children’s Hospital

Program Personnel

Dr Marianne Mégroz, Project Manager, Hudson Institute of Medical Research